The invention relates to the treatment of meningiomas using a composition including a cytotoxic agent and a compound selected from phenylbenzothiazole derivatives, stilbene derivatives, and biphenylalkyne derivatives.
Meningioma TreatmentTechnology #2010-312
Questions about this technology? Ask a Technology Manager
- Geoffrey B. Johnson M.D., Ph.D.
- Joseph E. Parisi M.D.
- Mark A. Nathan M.D.
- Val J. Lowe M.D.
- Managed By
- Bruce R. Kline
- Patent Protection
- US Patent Pending
- US Patent Pending US 2015/0157744 A1
- PCT Patent Application WO 2014/004664 A2